denosumab 120 mg

DRUG2 trials

Sponsors

GlaxoSmithKline, Borstkanker Onderzoek Groep

Conditions

Breast NeoplasmsOsteoporosis

Phase 1

China HVT Safety, PK, PD

CompletedNCT02135640

GlaxoSmithKlineOsteoporosis

Start: 2014-07-17End: 2015-02-17Updated: 2017-05-10

Phase 2

Study to Identify the Impact of Denosumab on the Immune System in Patients With HER2 Negative Breast Cancer

WithdrawnNCT03532087

Borstkanker Onderzoek GroepBreast Neoplasms

Start: 2018-02-28End: 2023-06-30Updated: 2020-01-18

Related Papers

Pharmacokinetics, pharmacodynamics, safety, and tolerability of single-dose denosumab in healthy Chinese volunteers: A randomized, single-blind, placebo-controlled study

PLoS ONE2018-06-2240 citations